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Abstract: Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and
autism spectrum disorder, and among those with fragile X syndrome, approximately 1/3rd meet a
threshold for an autism spectrum disorder (ASD) diagnosis. Previous functional imaging studies
of fragile X syndrome have typically focused on those with fragile X syndrome compared to either
neurotypical or autism spectrum disorder control groups. Further, the majority of previous studies
have tended to focus on those who are more intellectually able than is typical for fragile X syndrome.
In this study, we examine the impact of autistic traits in individuals with fragile X syndrome on a
paradigm looking at facial emotion processing. The study included 17 individuals with fragile X
syndrome, of whom 10 met criteria for autism as measured by the Autism Diagnostic Observation
Schedule (ADOS). Prior to the scan, participants rehearsed on a mock scanner to help acclimatize to
the scanner environment and thus allow more severely affected individuals to participate. The task
examined the blood-oxygen-level-dependent (BOLD) response to fearful and neutral faces taken
from the Ekman faces series. Individuals in the autism group had a region of significantly reduced
activity centered on the left superior temporal gyrus, compared to those with FXS alone, in response
to the fearful faces. We suggest that autism in individuals with fragile X syndrome is associated with
similar changes in the neurobiology of facial emotion processing as seen in idiopathic autism.
Keywords: fragile X syndrome; autism; functional imaging; emotion-processing
1. Introduction
Fragile X syndrome (FXS) is a neurodevelopmental disorder occurring in approximately 1
in 3000–4000 males and 1 in 6000–8000 females and is the leading inherited cause of intellectual
disability [1]. Further, a significant proportion of individuals with FXS meet diagnostic criteria for
autism, with FXS being the leading monogenic cause of autism.
It was recognized in some of the early described series of confirmed individuals with fragile X
syndrome that there were higher levels of autistic traits, by way of social, communication, and sensory
difficulties; than could be accounted for by level of intellectual disability alone [2–7]. In parallel,
early studies in which groups with autism were screened for fragile X reported that up to 16% of autistic
males had fragile X syndrome [8–13]. With autism now being more widely recognized, especially in
those without an intellectual disability, these estimates are consequently lower, with fragile X syndrome
accounting for approximately 0.5% of individuals with autism [14–16]. Despite the association between
autism and fragile X syndrome, in many cases, the presentation of autism in the context of FXS differs
subtly, but importantly, from the prototypical presentation in idiopathic autism [17] and it is not clear
to what extent the autistic traits reported in FXS are the result of the same underlying process as those
observed in idiopathic autism [18]. Whereas fragile X syndrome is a genetically-defined condition
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with a common phenotype, albeit with some variation in presentation, and an increased prevalence of
the disorder; autism itself is a condition defined by its behavioral phenotype and with a wide variety
of aetiologies, both known and unknown. Thus, as entities, they are categorically different, a theme
previously investigated and discussed by Hall et al. [19]. Of note, is that discussion about whether
autism in FXS is the same as idiopathic autism, is paralleled beyond FXS, with the validity of the idea
of autism across the spectrum representing the same entity being questioned, particularly in the light
of the revisions on ASD incorporated into DSM-5. This issue is far from new; indeed, even in the early
years of autism research, Kanner was bemoaning the same issue; feeling that his idea of a relatively
rare and pure entity was being challenged, noting that others appeared to wish to throw “diagnostic
criteria to the winds” [20]. Notwithstanding this issue, given the increased co-occurrence of autism in
FXS, the question of the nature of the overlap remains of interest.
One of the central features of autism is a difference in reciprocal social communication and
interaction. What underlies this from a biological basis has been the basis of a number of theories.
Whilst this likely varies across the various aetiologies of autism; given the clustering of features that
define autism, we may expect some shared underlying biology. One possible contributing factor is a
differential perception of facial emotional stimuli in autistic individuals, which may then contribute to
differences in social understanding, communication, and interaction. Whilst the majority of studies
show diminished facial emotion recognition in autistic individuals, there is significant variability
in the findings; with heterogeneity in study paradigms likely to explain at least part of this [21].
The time it takes for emotion recognition may also be an important difference [22], with individuals
with autism typically taking longer to recognize the emotion [23]. It should also be noted that
the direction of the relationship between facial emotion recognition and the impairments in social
interaction typical of autism is not entirely clear: diminished social interaction is likely to give less
exposure to facial stimuli and therefore interfere with development of the associated neural circuitry;
whilst primary difficulties in facial emotion recognition may make social interaction difficult [24].
Meta-analyses of emotion processing functional imaging studies in autism show recruitment of different
brain regions during facial emotion recognition, with regions of both hypo- and hyper-activation
seen [25,26]. Of these, the strongest and most consistent findings have been differences in activation
in the fusiform face area (FFA) and temporal structures. In the FFA, typically hypoactivation is seen
in individuals with autism [27–31]. In their review of studies reporting on FFA activation, Perlman
reports that this FFA hypoactivation was seen in two-thirds of studies, with equal activation seen in
the remainder [31]. With regards to the results in temporal structures, both hypo- and hyper-activation
have been reported [25,28,29,32,33], largely with a focus on the superior temporal gyrus and the
superior temporal sulcus.
Functional MRI imaging has been used in fragile X syndrome quite extensively to try and
better understand some of the key differences across individuals in a variety of domains, including
facial/emotion/gaze processing [34–40], auditory processing [41], cognitive functions (memory,
attention, cognitive interference, equivalence processing, arithmetic processing) [42–49], and functional
connectivity [50,51]. Interestingly, most of these studies have examined groups of individuals with
FXS of a mean age of 18 or below. It is important to consider that development continues throughout
adulthood, and differences may either emerge or diminish over time. As the field of research develops,
replications of these studies, as well as our own, in older adults would help to shine a further light on
the developmental trajectories and maturing brain in FXS.
The previous functional imaging studies of face and gaze processing in fragile X syndrome have
produced relatively heterogeneous findings [34–40]. As with the autism literature, this has likely been
the result of a combination of factors, including: imaging paradigm used, balance of gender, level
of intellectual functioning of the FXS group, and choice of comparison group. Of particular note is
that given the relationship (albeit not direct) between intelligence quotient (IQ) and fragile X mental
retardation protein (FMRP) levels [52], it is likely that at least some of the variability will be explained
by the wide range of group mean IQ (61–91) of the individuals in these studies, and thus the likely
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underlying FMRP levels. Of the 100 participants in these previous studies, there were 57 females and
43 males. Given that FXS is approximately twice as common in males as it is in females, this ratio of
male to female participants, likely represents somewhat of a selection bias for females. These factors,
at least in part, likely reflect the significant difficulties in recruiting and scanning individuals with
more significant intellectual impairment, who are more likely to be male.
In the fragile X syndrome studies of emotion processing concerned with individuals of mean IQ
<70 (i.e., considered to have an intellectual disability; a key feature of the full fragile X syndrome),
the results showed decreased prefrontal activation in FXS compared to typically-developing (TD)
controls [38,40]; increased left insula activation in FXS compared to TD controls [40]; left frontal gyrus
hypoactivation in FXS compared to TD controls [35]; and increased activation in left hippocampus,
left superior temporal gyrus, right insula, and left postcentral gyrus in FXS compared to TD and ASD
controls [35]. In the study of neural habituation to faces, the FXS group showed significant sensitization
and decreased habituation in cingulate gyrus, fusiform gyrus, and frontal cortex compared to IQ and
autism-matched controls [34].
In this study, we aimed to further explore the relationship between autism and emotion-processing
in individuals with fragile X syndrome. In particular, we were interested in whether the same patterns
of differential neural activation during emotion-processing seen in individuals with idiopathic autism
compared to typically-developing controls, would be seen in a group with FXS + autism, compared to
individuals with FXS alone. Our hypothesis was that we would see reduced activation in the FFA and
altered activity in superior temporal structures in the FXS + autism group.
2. Materials and Methods
2.1. Participant Recuritment
Initial recruitment was through the Fragile X Registry at The Patrick Wild Centre in Edinburgh.
With the support of the UK-based family support charity, The Fragile X Society, the study was also
advertised in their quarterly print newsletter and on their website. Subsequently, information sheets
and letters of invitation were sent out to families registered with the society as being interested in
research. Ethical permission for the study was granted by the National Research Ethics Service Scotland
A Research Ethics Committee (reference 12-SS-0117).
2.2. Imaging Procedure
Prior to their scan, participants were given the opportunity to rehearse the scanning procedure on
two mock scanners available. The first mock scanner had been built in the Patrick Wild Centre for a
previous study to facilitate desensitization to the scanning procedure, and was used extensively in
this study for rehearsal and acclimatization. A further mock scanner, housed in the Clinical Research
Imaging Centre (CRIC) was also used, and participants were able to rehearse on this immediately
prior to their main scan. This mock scanner was a replica of the main scanner used, with the only
difference being that it did not have a main coil. However, the use of earplugs, headphones, and an
audio recording of the scanning sequences used in the main scanner all helped to simulate the sensory
experience. Only when participants were comfortable in the mock scanner did they proceed to the main
scan. Eight individuals did not successfully proceed beyond the mock scanning stage. See Figure A1
(Appendix B) for details.
2.3. Imaging Sequences
All scans were completed on a Siemens MAGNETOM Verio 3T scanner. For the structural imaging,
using an MPRAGE sequence, a T1 structural image was obtained made up of 160 coronal slices of 1
mm slice thickness and 1 mm × 1 m × 1 mm voxels. A repetition time (TR) of 2.3 s, an echo time (TE)
of 2.98 ms, flip angle of 9◦, and field of view (FOV) of 256 mm were used. For the functional imaging,
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159 volumes were acquired; each containing 26, interleaved, 5 mm slices of voxels 3.4 mm × 3.4 mm ×
5 mm. In this case a TR of 1.56 s, a TE of 26 ms, flip angle of 66◦ and FOV of 220 mm were used.
The functional imaging task used was a block-design task with two main conditions, including a
series of neutral faces, and a series of fearful faces, the faces being taken from the Pictures of Facial
Affect series [53]. We used the fearful and neutral stimuli as differences in the processing of fearful
stimuli have been shown to be particularly affected in autism [33].
A visual fixation cross was presented at the beginning and end of the sequence, as well as between
the conditions of interest. In the contrasts comparing against baseline, the fixation cross was considered
as the baseline condition. The complete sequence presented six blocks, each of six faces alternating
between blocks of fearful or neutral faces. Within each block, each face was shown for 3.5 s with an
inter-stimulus interval of 0.5 s. In between each block was an interval of 12.5 s during which a fixation
cross was shown. There were two variations of the sequence, with one starting with a block of neutral
faces and the other starting with a block of fearful faces; these sequences being balanced across the
groups. As had been rehearsed in the mock scanners, participants were asked to depress a trigger
button each time they saw an image. This was principally used as an in-scan method for ensuring
participants were attending to the task, with participants needing to respond successfully on more
than 80% of faces to be included in further analysis.
2.4. Image Processing and Analysis
2.4.1. Preprocessing of fMRI Data
Images were processed and analysed using the Statistical Parametric Mapping (SPM) program
(version 12, Functional Imaging Laboratory, Wellcome Trust Centre for Human Neuroimaging,
University College London, London, UK; fil.ion.ucl.ac.uk/spm/) running within Matlab (R2011b
(version 7.13.0.564), MathWorks, Natick, MA, USA). The ArtRepair toolbox version 5b3 [54] for
SPM was used to analyze and repair motion artefacts using the single subject pipeline described by
Mazaika [55]. Full details of the preprocessing pipeline are contained in Appendix A.
2.4.2. Statistical Analysis of fMRI Data
For each contrast examined, a design matrix was created incorporating weightings for the neutral
and fear conditions. A 128-s high-pass filter was used to remove slow signal drifts. Second-level
analyses were generated using these first level contrast images for each participant to consider
differences in activation, both within groups and between groups. The initial height threshold was set
at p < 0.001 uncorrected with results considered significant at p < 0.05 at cluster level after family-wise
error correction. Age was included as a covariate of no interest in the between-group analyses given
the trend towards a significant difference between the two groups on age.
2.5. Measure of Cognitive Ability
The Kaufman Brief Intelligence Test (K-BIT) was used with all participants as a measure of
cognitive ability. The K-BIT comprises of three sub-tests (Verbal Knowledge, Riddles, and Matrices)
and takes approximately 20 min to complete [56], giving verbal, performance, and composite IQ scores.
2.6. Measure of Autistic Traits
The Autism Diagnostic Observation Schedule-2 (ADOS-2, henceforth, simply referred to as
‘ADOS’) was used to directly measure autistic traits. The ADOS is a semi-structured interview that
uses a set of prescribed ‘presses’ to elicit, demonstrate, or create the space in which autistic features
may be assessed either by the presence or absence of features that are useful in helping to establish
an autism diagnosis [57]. This format allows for the assessment of autistic and associated features
including 31 items across 5 domains. The 5 domains include the domains considered in autism
Genes 2019, 10, 1052 5 of 14
diagnosis (social, communication, and stereotyped behaviors and restricted interests) plus the related
domains of creativity and associated features.
For each participant, we used the cutoff of a combined social and communication total of ≥10 to
divide the group into ‘FXS’ and ‘FXS + autism’ groups for the between-group analyses. Calibrated
Severity Scores (CSS) were also calculated using the published algorithms, to provide a continuous
measure of autistic traits for regression analysis. In the case of the participants who were scored on the
ADOS module 4, the CSS algorithm subsequently published by Hus & Lord [58] was used.
3. Results
3.1. Feasibility of Functional Imaging in Fragile X Syndrome
Of the individuals who received the invitation to participate, or who saw the study advertisement,
a total of 58 expressed interest. After discussion by telephone, 32 of these participants and their
families attended an initial visit and trial on the mock scanner. Of those who did not progress from
an expression of interest to a visit, a number of reasons were cited; however, for most it was the
combination of all the barriers (principally distance, travel, and logistics) that were reported as being
the reason not to progress. In many cases, these reasons should also be considered in the context
of the participant’s and family’s uncertainty as to whether the participant would actually be able to
successfully complete the scanning sequence. Of 32 participants who attended an initial visit and trial
on the mock scanner, 22 attended the main scanner visit, 21 completed a structural scan, 18 completed a
functional scan, and 17 were included in the analyses. Figure A1 (Appendix B) lays out the recruitment
path from initial approach to completed scans.
As expected, the biggest dropout after attending an initial visit was between the mock scanner
trial and the main scanner visit, emphasizing the screening role that the opportunity to rehearse on the
mock scanner can provide. Whilst most of the participants had not had prior contact with the research
team, a significant proportion (41%) had been involved with previous studies at The Patrick Wild
Centre, and were already familiar with the staff, facilitating participation.
3.2. Investigating the Role of Autism in Mediating Facial Emotion Processing
To consider the relative impact of autistic traits on facial emotion processing, the data were
examined in two separate ways. Firstly, by dividing the participants into two groups: those meeting
the ADOS threshold for autism (social and communication total ≥10) and those not (social and
communication total <10); contrasts were examined in SPM comparing the groups. Secondly,
we calculated Calibrated Severity Scores (CSS) from the raw ADOS data using the published algorithms.
These scores were then regressed against the contrast of interest within the autism group alone.
3.2.1. Between-Group Analyses
In these analyses, we compared the response to each contrast between the groups of those
with FXS alone and those with FXS + threshold autism traits on the ADOS. The makeup of the two
subgroups is shown in Table 1. In general, the use of prescription medication in the participants was
low, with only four participants taking regular psychoactive medication. All four participants were
taking mavoglurant (AFQ056, Novartis AG, Basel, Switzerland); one in the non-autism group and
three in the autism group. We consider the relatively low use of psychoactive medications in the
sample to likely represent a combination of prescribing practice in the U.K. and likely a degree of
selection bias—that those who were more affected and thus more likely to be on medication, were less
likely to be able to participate. Further, our sample was on average older than those in most studies.
As such, whilst a number of participants had been on psychoactive medications as children; they were
no longer on them. Epilepsy, whilst more common in FXS, was under-represented in this sample, with
no participants being treated for epilepsy.
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Table 1. Baseline details of participants included in the imaging analyses.
Autism Group Non-Autism Group
N 10 7
Male: female 8:2 5:2
Age 18 (6.2) 27 (11.7)
Full-scale IQ 59 (8.9) 63 (14.2)
Verbal IQ 69 (11.9) 71 (14.2)
Performance IQ 58 (11.1) 60 (14.4)
ADOS Total 15 (10–20) 2 (0–5)
ADOS CSS 8 (6–10) 2 (1–2)
Results show group means (s.d.) for age and IQ and median (range) for the ADOS scores. The groups were
not significantly different on gender (p = 0.682), age (p = 0.092), full-scale IQ (p = 0.528), verbal IQ (p = 0.695) or
performance IQ (p = 0.704). ADOS, Autism Diagnostic Observation Schedule; CSS, Calibrated Severity Score.
In the analysis comparing response to fearful faces versus baseline, there was a region of
significantly different activity between the groups centered on the left superior temporal gyrus (STG)
and extending to the rolandic operculum and supramarginal gyrus. Specifically, this region showed
significantly greater activation in the FXS group, compared to the FXS + autism group. Co-ordinates in
Montreal Neurological Institute (MNI) space for this cluster are given in Table 2. The cluster is shown
in Figure 1a and the extracted values of the Eigenvariates are plotted in Figure 1b. The cluster remains
significant (pFWE-corr = 0.002; kE = 511; Z≡ = 4.52; x, y, z = −64, −30, 22) when including medication use
as a covariate.
Table 2. Region of significantly different response to fearful faces between FXS and FXS + autism groups.
Cluster pFWE-corr kE Z≡ x y z
Left superior temporal gyrus 0.001 570 4.45 −64 −30 22
Significance given as cluster-level, familywise-error corrected value. x, y, z co-ordinates given in MNI space.
Figure 1. (a) Cluster of significantly greater brain activation in the non-autism group, compared to
the autism group during the fearful faces versus baseline contrast. Region projected on the canonical
single subject T1 image from SPM12. (b) Extracted Eigenvariate values in the two groups from the
cluster shown in panel (a).
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There were no clusters of significant difference between the groups when considering response to
neutral faces vs. baseline, or on the more subtle contrast of fearful faces vs. neutral faces. Whilst we
did see the expected activation in the fusiform face area in both groups in response to the facial stimuli
(both fearful and neutral), there were no between-group differences found.
3.2.2. Correlation between ADOS Calibrated Severity Score and Response to Fearful and Neutral Faces
In this analysis, the calculated CSS score was regressed against response to each of: all faces,
neutral faces, and fearful faces in the autism subgroup. There was a cluster of positive correlation
between CSS score and the response to all faces, as reported in Table 3. The region is shown in Figures 2
and 3 shows the correlation between CSS and the extracted value of the cluster Eigenvariates.
Table 3. Region of significant correlation between ADOS Calibrated Severity Score and response to all
facial stimuli.
Cluster pFWE-corr kE Z≡ x y z
Left cerebellum, anterior lobe, lobules IV/V 0.029 198 4.01 −24 −42 −34
Significance given as cluster-level, familywise-error corrected value. x, y, z co-ordinates given in MNI space.
Figure 2. Cluster of activation significantly correlated with ADOS Calibrated Severity Score in the
autism subgroup. Region projected on the canonical single subject T1 image from SPM12.
While there was no significant correlation to either of the neutral > baseline or fear > baseline
contrasts at a whole-brain level, a small volume correction (SVC) centered on the area of significant
activation for the faces > baseline contrast was used to investigate which contrast was driving the
faces > baseline result. Using this SVC, an area of significant activation was identified in the neutral >
baseline contrast, whereas there was no significant activation in this area under the fear > baseline
contrast. The results are shown in Table 4.
Table 4. Region of significant correlation between ADOS Calibrated Severity Score and response to
neutral facial stimuli using the small volume correction described.
Cluster pFWE-corr kE Z≡ x y z
Left cerebellum, anterior lobe, lobules IV/V 0.006 27 3.70 −20 −38 −30
Significance given as cluster-level familywise-error corrected value. x, y, z co-ordinates given in MNI space.
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Figure 3. Scatter plot of the correlation between extracted Eigenvariate value and Calibrated Severity
Score (CSS) from the cluster shown in Figure 2. The solid line shows the linear regression, with the
dotted lines demarcating the 95% confidence bands.
4. Discussion
In this study, we explored the role of autism in facial emotion processing in individuals with
fragile X syndrome. Previous functional imaging studies of facial emotion processing in both autism
and FXS had suggested that differences in activation in the fusiform face area and the superior temporal
gyrus were the most robust findings. Interestingly, whilst we did elicit significant FFA activation at a
whole group level, we did not detect any differences between the groups.
However, our finding of significantly reduced activation in the left superior temporal gyrus
(STG) / superior temporal sulcus (STS) in those with FXS+ autism compared to those with FXS alone
overlaps the previous findings in individuals with idiopathic autism [26]. Our result also replicates
the finding of Dalton of increased activity in the same region in individuals with FXS compared to
both typically-developing and autism controls [35]. Interestingly, in the FXS group reported by Dalton,
none of them had a clinical diagnosis of autism, and the group had relatively low average autistic traits,
as measured by the Social Communication Questionnaire (SCQ) (mean SCQ of 9). Thus, we suggest
that the FXS group studied by Dalton is likely to be comparable to our non-autism FXS group. Taken all
together, the result suggests that autism, whether idiopathic or associated with FXS, may be associated
with the same impact on the neurological underpinnings of facial emotion processing.
Our finding in the cerebellum of a correlation between activation to neutral faces and CSS
scores is interesting in that the findings for the role of the cerebellum in social processing in autism
have generally been that cerebellar activation is diminished in individuals with autism compared to
typically-developing controls [59–62]. However, in their meta-analysis of 350 fMRI studies examining
the role of the cerebellum and social cognition, Van Overwalle et al. suggest that cerebellar activity
may actually increase when the level of abstraction in the task increases, and with it the demand on
executive resource [63]. If neutral faces are considered to be more ambiguous and thus may appear
more abstract than overtly emotional (in this case, fearful) faces, then this may be an explanation for
the finding. However, given that this finding is largely in contrast to the literature, we think it only
appropriate to be circumspect with regard to this finding. Further, given its level of significance at a
whole brain level, we can be less confident in it. Indeed, correcting for multiple comparisons, the result
would no longer be significant.
In the between-group comparisons, we were looking at three main contrasts: response to neutral
faces versus baseline, response to fearful faces versus baseline, and response to fearful faces versus
neutral faces. Although the only significant differences that we noted were in the fearful versus baseline
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contrast, as noted in the results, we did not find any group differences on the fearful versus neutral
contrasts. We therefore cannot specifically ascribe our findings to the processing of emotional content
per se and it is possible that they relate to more general face processing differences.
Beyond the findings from our imaging analysis, we also describe the methods used in successfully
imaging a cohort of individuals with fragile X syndrome who were more intellectually impaired
than many participants in prior studies. The mean full scale IQ of individuals in this study was 60.9,
while images were successfully acquired in individuals with IQ as low as 40. Using these methods,
we have, therefore, shown that it is possible to successfully image people with FXS and significant ID.
We hope that the descriptions of methods used and the description of where participants dropped out
from the study will be of use to other researchers in planning similar studies.
4.1. Limitations
4.1.1. Participants
The study has a number of limitations. Firstly, as with many of the previous imaging studies in
fragile X syndrome, larger numbers would have provided more power to detect more subtle group
differences. Nonetheless, this is still one of the larger functional imaging study of males with FXS
and we hope that it can add to the literature. Acknowledging the difficulties in recruiting the most
severely affected individuals, there was likely a degree of selection bias; with a number of potential
participants either not responding to the invitations, or dropping out once they had tried the mock
scanner. In terms of comparison or control groups, previous studies in FXS have taken a variety
of approaches: typically-developing controls, ASD controls, typically-developing developmental
age-matched controls or developmental delay controls. In this study, we were interested in the effect
of autism on individuals with FXS and thus chose to compare two groups of individuals with FXS;
one with high autistic features, and one without. It would have been interesting to also include further
comparison groups; however, that was beyond the scope of this study, although is a focus of currently
ongoing work.
4.1.2. Measures
The ADOS, whilst commonly used, is not validated for use in adults with such significant
intellectual disability; although the bimodal distribution of both ADOS total and CSS scores gives a
degree of confidence that our groups represented individuals with significant differences in social
communication and interaction. Had we chosen the lower threshold of ≥7 for autism spectrum
disorder as published in the ADOS, we would still have had groups of the same makeup. Further,
the ADOS was completed by two researchers (A.G.M. (consultant psychiatrist) & S.C. (clinical &
research psychologist)) who are trained as research-reliable ADOS users, adding to the degree of
reliability that can be afforded to the findings. A full clinical workup considering autism diagnosis,
would of course have been preferable, however, was not feasible within the constraints of the study.
4.1.3. fMRI Paradigm and Acquisition
During the acquisition of the imaging data, we used a trigger for the participants to indicate
when they had seen a face, with participants needing to respond successfully on more than 80% of
faces to be included in further analysis. However, our scanning facility unfortunately did not have
in-scanner eye-tracking available, and as such we do not know for how long, or with what pattern,
the participants visually attended to the stimuli. Given that both FXS and autism are associated with
gaze aversion, and that there may be a group difference on gaze, we cannot be confident that our results
do not represent differences in gaze, either instead of, or as well as, differences in underlying neural
processing. The use of a fixation cross as baseline also means that we cannot attribute our findings
specifically to face processing, as opposed to more general visual perceptual differences between the
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groups. Future research should include eye-tracking combined with a higher-level baseline, such as a
scrambled face, to address this.
5. Conclusions
In this study, we have shown that autism in individuals with fragile X syndrome is associated
with the same reduction in activation in the left superior temporal gyrus, as is seen in individuals
with both idiopathic autism, compared to typically-developing controls; and in idiopathic autism,
compared to non-autistic individuals with FXS. This supports the idea that autism in FXS may, at least
in part, represent a good model for autism more broadly.
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Appendix A
Images were analyzed using the Statistical Parametric Mapping (SPM) program (version 12,
Functional Imaging Laboratory, Wellcome Trust Centre for Human Neuroimaging, University College
London, London, UK; fil.ion.ucl.ac.uk/spm/) running within Matlab (R2011b (version 7.13.0.564),
MathWorks, Natick, MA, USA). Data were initially reconstructed using the DICOM Import function
within SPM for further processing within SPM.
Prior to pre-processing, the first seven volumes of the functional scans were discarded to reduce
the impact of T1 equilibrium effects. Images were initially realigned to the mean EPI image using
the Realign (realign and unwarp) module of SPM. The T1 structural image was co-registered to the
mean EPI image. The images were realigned, before being smoothed with a 4 mm FWHM Gaussian
smoothing kernel. The ArtRepair toolbox version 5b3 [54] for SPM was used to first examine and then
repair the volumes, using the art_motionregress and art_global modules of the single subject pipeline
described by Mazaika [55] The art_motionregress algorithm of ArtRepair was used as an alternative to
adding the movement parameters in the design matrix, as the motion regressors have been described
as not being sufficiently accurate to account for the relatively larger movements of clinical subjects [64].
The images were subsequently analyzed and repaired using the art_global module in ArtRepair. In this
step, the volumes were examined for fast head movements, and volumes with movement of >0.5
mm/TR were interpolated with the nearest usable volumes. 10/17 scans had to be repaired in this way.
Where a scan had >20% of volumes with >0.5 mm/TR movement, the scan was excluded. Only 1 scan
had to be excluded for this reason. The T1 structural image was segmented before both structural
and functional images were normalized using normalization parameters arising from the T1 image
segmentation. Finally, a 7 mm kernel was used in a second smoothing step; the combination of 4 mm
and 7 mm smoothing being approximately equivalent to the commonly-used single 8 mm kernel [64].
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Appendix B
Figure A1. CONSORT diagram of recruitment and scanning. FXSoc—Fragile X Society.
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